116 related articles for article (PubMed ID: 3524928)
1. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients.
Hirakata H; Onoyama K; Hori K; Fujishima M
Clin Nephrol; 1986 Jul; 26(1):27-32. PubMed ID: 3524928
[TBL] [Abstract][Full Text] [Related]
2. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA
Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
[TBL] [Abstract][Full Text] [Related]
5. Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients.
Onoyama K; Sanai T; Motomura K; Fujishima M
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S27-30. PubMed ID: 2474097
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
7. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
8. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
9. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
11. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
Rasmussen S; Ibsen H; Giese J
Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
[TBL] [Abstract][Full Text] [Related]
13. Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man.
Lijnen P; Verschueren LJ; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):293-301. PubMed ID: 6152995
[TBL] [Abstract][Full Text] [Related]
14. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
16. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
17. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
18. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
[TBL] [Abstract][Full Text] [Related]
19. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
20. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
Schoorl M; Schoorl M; Nubé MJ; Bartels PC
Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
